1-2 of 2
John Puskas, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Results of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)

David A Sallman, MD, Amy E. DeZern, MD, Guillermo Garcia-Manero, MD, David P. Steensma, MD, Gail J. Roboz, MD, Mikkael A. Sekeres, MD MS, Thomas Cluzeau, MD PhD, Kendra L. Sweet, MD, Amy F McLemore, M.S., Kathy McGraw, PhD, John Puskas, PhD, Ling Zhang, MD, Jiqiang Yao, PhD, Qianxing Mo, PhD, Lisa Nardelli, Najla Al Ali, M.Sc, Eric Padron, MD, Greg Korbel, PhD MBA, Eyal C. Attar, MD, Hagop M. Kantarjian, MD, Jeffrey E. Lancet, MD, Pierre Fenaux, MD PhD, Alan F. List, MD, Rami S. Komrokji, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 676.
https://doi.org/10.1182/blood-2019-131055
Published: 2019
Journal Articles

Phase 1b/2 Combination Study of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

David A Sallman, MD, Amy E. DeZern, MD, David P. Steensma, MD, Kendra L. Sweet, MD, Thomas Cluzeau, MD PhD, Mikkael A. Sekeres, MD MS, Guillermo Garcia-Manero, MD, Gail J. Roboz, MD, Amy F McLemore, M.S., Kathy L McGraw, PhD, John Puskas, PhD, Ling Zhang, MD, Chirag K Bhagat, PharmD, Jiqiang Yao, PhD, Najla Al Ali, M.Sc, Eric Padron, MD, Roger Tell, MD PhD, Jeffrey E. Lancet, MD, Pierre Fenaux, MD PhD, Alan F. List, MD, Rami S. Komrokji, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3091.
https://doi.org/10.1182/blood-2018-99-119990
Published: 2018